Showing results (2401-2410 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|September 24, 2016
Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancersChengyan Jin, Xingyi Zhang, Mei Sun, et al.Oncotargets and Therapy|September 24, 2016
Sunitinib: the antiangiogenic effects and beyondZhonglin Hao, Ibrahim SadekOncotargets and Therapy|September 24, 2016
Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese populationRui-Xi Hua, Zhen-Jian Zhuo, Guo-Ping Shen, et al.Oncotargets and Therapy|September 28, 2016
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patientsAli Suner, Hakan Buyukhatipoglu, Gokmen Aktas, et al.Oncotargets and Therapy|September 28, 2016
The association of PTEN hypermethylation and breast cancer: a meta-analysisShanshan Luo, Jiansi Chen, Xianwei MoOncotargets and Therapy|May 2, 2018
Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cellsShuxian An, Liangqian Huang, Ping Miao, et al.Oncotargets and Therapy|May 2, 2018
The role of Hippo signal pathway in breast cancer metastasisChangran Wei, Ying Wang, Xiangqi LiOncotargets and Therapy|May 2, 2018
miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expressionLiuxue Du, Tianpei Chen, Kai Zhao, et al.Oncotargets and Therapy|May 8, 2018
Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapyYang Zhang, Zongjuan Li, Wei Zhang, et al.Oncotargets and Therapy|July 25, 2018
miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathwayChuansheng Li, Jingwei Zhang, Zhongliang Ma, et al.Pageof 672